Phase 2 trial of Abraxane, albumin-bound paclitaxel, in patients with previously treated non-small cell lung cancer

Phase 2 trial of Abraxane, albumin-bound paclitaxel, in patients with previously treated non-small cell lung cancer - Phase 2 trial of albumin-bound paclitaxel in patients with previously treated non-small cell lung cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000010841

Enrollment

Registered

2013-06-01

Start date

2013-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Previously treated non-small cell lung cancer

Interventions

Chemotherapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with non-small cell lung cancer previously trearted with one regimen of chemotherapy

Exclusion criteria

Exclusion criteria: Patients with non-small cell lung cancer previously trearted with paclitaxel

Design outcomes

Primary

Measure	Time frame
Response rate and the rate without progressive disease	—

Secondary

Measure	Time frame
OS, PFS, and safety	—

Countries

Japan

Contacts

Public ContactTamotsu Ishizuka

University of Fukui Hospital Division of Respiratory Medicine

tamotsui@u-fukui.ac.jp0776-61-8355

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026